Institutional investors purchased a net $11.1 million shares of AZN during the quarter ended December 2014 and now own 7.49% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FINANCIAL MANAGEMENT, ... Bought 27.5 Thousand shares of AstraZeneca
CAPSTONE ASSET MANAGEMENT CO. Bought 7.3 Thousand shares of AstraZeneca
DANIEL DEVINE & CO. Bought 3.7 Thousand shares of AstraZeneca